Evidence map›Paper›PMID 28761654›Full record

ArticleBMJ open diabetes research & care2017

Treatment patterns and clinical characteristics of patients with type 2 diabetes mellitus according to body mass index: findings from an electronic medical records database.

Wayne Weng, Ye Tian, Edward S Kimball, Sheldon X Kong, Jonathan Bouchard, Todd M Hobbs, Brian Sakurada

Open access · goldAbstract read
In one paragraph

Article in BMJ open diabetes research & care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Tirzepatide as an Add-on for Participants with Inadequate Glycemic Control Using Basal Insulin: Pooled Subgroup Analysis of SURPASS-5 and -6.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Trends in HbA1c and Body Mass Index Among Individuals with Type 2 Diabetes: Evidence from a US Database 2012-2019.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Wayne WengDepartment of Health and Economics Outcomes Research, Novo Nordisk, Plainsboro, New Jersey, USA.
Ye TianDepartment of Health and Economics Outcomes Research, Novo Nordisk, Plainsboro, New Jersey, USA.
Edward S KimballMedical Writing and Education, Novo Nordisk, Plainsboro, New Jersey, USA.
Sheldon X KongDepartment of Health and Economics Outcomes Research, Novo Nordisk, Plainsboro, New Jersey, USA.
Jonathan BouchardDepartment of Health and Economics Outcomes Research, Novo Nordisk, Plainsboro, New Jersey, USA.
Todd M HobbsDepartment of Diabetes and Obesity, Novo Nordisk, Plainsboro, New Jersey, USA.
Brian SakuradaMedical Affairs, Novo Nordisk, Plainsboro, New Jersey, USA.
Novo Nordisk (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study evaluated relationships between glycaemic control, body mass index (BMI), comorbidities and pharmacological treatment in patients with type 2 diabetes mellitus (T2D). RESEARCH DESIGN AND

methodsThis was a retrospective, cross-sectional analysis of Quintiles electronic medical records research data (study period 1 October 2013-30 September 2014). Eligibility included age ≥18 years, T2D diagnosis, and at least one available BMI measurement.

resultsThe study included 626 386 patients (mean age, 63.8 year; 51.3% female; 78.5% white; 62.6%, BMI ≥30 kg/m

conclusionsThis large dataset provides evidence that roughly one out of four patients with T2D is not well controlled, and the prevalence of poor glycaemic control increases as BMI increases.

Indexed as

Comorbidityglycaemic controlobesityType 2 diabetes

Identifiers

PMID28761654
PMCPMC5530246
OpenAlexW2617980875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.